Literature DB >> 32140491

Predictive value of spleen stiffness in hepatocellular carcinoma.

Matthias Buechter1,2, Alisan Kahraman1.   

Abstract

Entities:  

Year:  2020        PMID： 32140491      PMCID： PMC7026802          DOI： 10.21037/hbsn.2019.09.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  7 in total

1.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

2.  Spleen in hepatocellular carcinoma: More complexity and importance than we knew.

Authors:  Wei Wei; Liang Li; Guangyao Kong; Zhongqiang Zheng; Fanpu Ji; Zongfang Li
Journal:  J Hepatol       Date:  2019-01-22       Impact factor: 25.083

3.  Pathological findings that contribute to tissue stiffness in the spleen of liver cirrhosis patients.

Authors:  Reiichiro Kondo; Masayoshi Kage; Hiroko Iijima; Jiro Fujimoto; Takashi Nishimura; Nobuhiro Aizawa; Jun Akiba; Yoshiki Naito; Hironori Kusano; Masamichi Nakayama; Yutaro Mihara; Masahiko Tanigawa; Hirohisa Yano
Journal:  Hepatol Res       Date:  2018-06-07       Impact factor: 4.288

4.  Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

Authors:  Judith Ertle; Alexander Dechêne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer; Gernot Kaiser; Jörg F Schlaak; Guido Gerken; Wing-Kin Syn; Ali Canbay
Journal:  Int J Cancer       Date:  2011-03-14       Impact factor: 7.396

5.  Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation.

Authors:  Matthias Buechter; Paul Manka; Jens M Theysohn; Marcus Reinboldt; Ali Canbay; Alisan Kahraman
Journal:  Dig Liver Dis       Date:  2017-10-10       Impact factor: 4.088

6.  Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.

Authors:  Giovanni Marasco; Antonio Colecchia; Agostino Colli; Federico Ravaioli; Giovanni Casazza; Maria Letizia Bacchi Reggiani; Alessandro Cucchetti; Matteo Cescon; Davide Festi
Journal:  J Hepatol       Date:  2018-10-31       Impact factor: 25.083

7.  Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?

Authors:  A Hüsing-Kabar; T Meister; M Köhler; W Domschke; I Kabar; C Wilms; B Hild; H H Schmidt; H S Heinzow
Journal:  United European Gastroenterol J       Date:  2017-09-20       Impact factor: 4.623
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.